Nicholas A. Magnus

1.3k citations

36 papers · 1.1k indexed · h-index 18

Organic Chemistry top 2%
- Asymmetric Synthesis and Catalysis 6
- Synthetic Organic Chemistry Methods 6
- Chemical synthesis and alkaloids 4
Pharmaceutical Science top 2%
Inorganic Chemistry top 10%
- Asymmetric Hydrogenation and Catalysis 3
Process Chemistry and Technology
Virology
Molecular Biology
- Chemical Synthesis and Analysis 6
Oncology
- Cancer Treatment and Pharmacology 5
Infectious Diseases
- HIV/AIDS drug development and treatment 4
Pharmacology
- Plant-based Medicinal Research 4

Co-authors: Pat N. Confalone P. Magnus Rodney L. Parsons William A. Nugent Soo S. Ko George L. Trainor Michael A. Staszak Sharon Diamond
Cited by: Organic Chemistry Pharmaceutical Science Inorganic Chemistry
Partner nations: United States Ireland United Kingdom

In The Last Decade

Nicholas A. Magnus

35 papers receiving 1.0k citations

Peers

Countries citing papers authored by Nicholas A. Magnus

Since Specialization

Citations

This map shows the geographic impact of Nicholas A. Magnus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas A. Magnus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas A. Magnus more than expected).

Fields of papers citing papers by Nicholas A. Magnus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas A. Magnus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas A. Magnus. The network helps show where Nicholas A. Magnus may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nicholas A. Magnus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nicholas A. Magnus Line = papers co-authored together Nicholas A. Magnus links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of a Scalable Process for an IL-17A Inhibitor LY3509754: Part III. Assembly of Drug Substance, Salt Formation, and Impurity Control Qiang Yang,Ryan J. Linder,Yu Lu,Thomas J. Beauchamp,Timothy A. Woods,David A. Coates,Brandon J. Reizman,Jonas Y. Buser,Michael E. Laurila,Nicholas A. Magnus,Yongjie Yu,Lili Han,Ping Huang	2025	2
2	Mechanistic Evidence for Mild Base-Mediated Intermolecular Trans-Aminoacylations of 1-Acyl-5-amino-1H-1,2,4-triazoles and 5-Amino-1H-1,2,4-triazoles to Afford 5-Acylamino-1H-1,2,4-triazoles Nicholas A. Magnus,Natalie G. Franklin-Charlesworth,Jesús González,James Muir	2024	0
3	Cyclization of Methyl-Coumalate-Derived Methyl 1-Benzamido-6-oxo-1,6-dihydropyridine-3-carboxylates: Assembly of the [1,2,4]Triazolo[1,5-a]pyridine Ring System Harold Moloney,Nicholas A. Magnus,Jonas Y. Buser,Matthew C. Embry	2017	11
4	Exploring the Scope of Asymmetric Synthesis of β-Hydroxy-γ-lactams via Noyori-type Reductions Denis Lynch,Rebecca E. Deasy,Leslie‐Ann Clarke,Catherine N. Slattery,U. B. Rao Khandavilli,Simon E. Lawrence,Anita R. Maguire,Nicholas A. Magnus,H.A. Moynihan	2016	9
5	Synthesis of an ORL-1 Receptor Antagonist via a Radical Bromination and Deoxyfluorination to Afford a gem-Difluorospirocycle Amy C. DeBaillie,C. David Jones,Nicholas A. Magnus,Carlos Mateos,Alicia Torrado,James P. Wepsiec,Tokala Ramachandar,Prasad Raje	2014	10
6	Diarylketone Ketoreductase Screen and Synthesis Demonstration to Access mGlu2 Receptor Potentiators Nicholas A. Magnus,Donald S. Coffey,Amy C. DeBaillie,C. David Jones,Iwona Kaluzna,Spiros Kambourakis,Yangwei John Pu,Lin Wang,James P. Wepsiec	2011	8
7	Synthesis of a Glycogen Synthase Kinase-3 Inhibitor Nicholas A. Magnus,Christopher P. Ley,Pamela M. Pollock,James P. Wepsiec	2010	1
8	Pictet−Spengler Based Synthesis of a Bisarylmaleimide Glycogen Synthase Kinase-3 Inhibitor Nicholas A. Magnus,Christopher P. Ley,Patrick M. Pollock,James P. Wepsiec	2010	11
9	Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine David M. Bender,Jingqi Bao,Anne H. Dantzig,William D. Diseroad,Kevin L. Law,Nicholas A. Magnus,Jeffrey A. Peterson,E.J. Perkins,Yangwei John Pu,Susan M. Reutzel‐Edens,David M. Remick,James J. Starling,Gregory A. Stephenson,Radhe K. Vaid,Deyi Zhang,James R. McCarthy	2009	94
10	The Synthesis of a 5HT_2C Receptor Agonist L. Hobson,William A. Nugent,Stephen Anderson,Subodh S. Deshmukh,James J. Haley,Pingli Liu,Nicholas A. Magnus,Patrick J. Sheeran,James P. Sherbine,Benjamin R. P. Stone,Jiang Zhu	2007	27
11	Synthesis of Imidazole Based p38 MAP (Mitogen-Activated Protein) Kinase Inhibitors under Buffered Conditions Nicholas A. Magnus,William D. Diseroad,C. Richard Nevill,James P. Wepsiec	2006	8
12	General Scope of 1,4-Diastereoselective Additions to a 2(3H)-Quinazolinone: Practical Preparation of HIV Therapeutics Nicholas A. Magnus,Pat N. Confalone,Louis Storace,Mona Patel,Christopher C. Wood,Wayne P. Davis,Rodney L. Parsons	2002	42
13	Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors Jeffrey W. Corbett,Soo S. Ko,James D. Rodgers,Lisa A. Gearhart,Nicholas A. Magnus,Lee T. Bacheler,Sharon Diamond,Susan Jeffrey,Ronald M. Klabe,Beverly C. Cordova,Sena Garber,Kelly Logue,George L. Trainor,Paul Anderson,Susan Erickson‐Viitanen	2000	272
14	Synthetic and Mechanistic Studies on the Azabicyclo[7.3.1]enediyne Core and Naphtho[2,3-h]quinoline Portions of Dynemicin A Philip Magnus,Shane A. Eisenbeis,Robin A. Fairhurst,Theodore Iliadis,Nicholas A. Magnus,David M. Parry	1997	30
15	Direct C-11 functionalisation of anatoxin-a. Application to the synthesis of new ligand-based structural probes Nicholas A. Magnus,Laurent Ducry,Valérie Rolland,Susan Wonnacott,Timothy Gallagher	1997	6
16	Induction of molecular asymmetry by a remote chiral group Patrick Linnane,Nicholas A. Magnus,P. Magnus	1997	45
17	Taxane diterpenes 2: Synthesis of the 7-deoxy ABC taxane skeleton, and reactions of the A-ring P. Magnus,John Booth,Louis J. Diorazio,Timothy J. Donohoe,V. Lynch,Nicholas A. Magnus,J. S. MENDOZA,Philip J. Pye,James Tarrant	1996	18
18	New strategy for the synthesis of the taxane diterpenes: Formation of the BC-rings of taxol via a [5+2]-pyrylium ylide-alkene cyclization, ring expansion strategy William E. Bauta,John Booth,Mary Ellen Bos,Mark R. DeLuca,Louis J. Diorazio,Timothy J. Donohoe,Nicholas A. Magnus,P. Magnus,J. S. MENDOZA,Philip J. Pye,James Tarrant,Stephen Thom,Feroze Ujjainwalla	1995	18
19	New strategy for the synthesis of the taxane diterpenes: Formation of the A-ring and introduction of the C-1 hydroxyl group Philip Magnus,John Booth,Nicholas A. Magnus,James Tarrant,Stephen Thom,Feroze Ujjainwalla	1995	10
20	A concise synthesis of the anthraquinone portion of dynemicin A Phillip Magnus,Shane A. Eisenbeis,Nicholas A. Magnus	1994	21

About Nicholas A. Magnus

Nicholas A. Magnus is a scholar working on Organic Chemistry, Pharmacology and Process Chemistry and Technology, having authored 36 papers that have together received 1.1k indexed citations. Recurring topics across this work include Asymmetric Synthesis and Catalysis (6 papers), Chemical Synthesis and Analysis (6 papers), Synthetic Organic Chemistry Methods (6 papers), Cancer Treatment and Pharmacology (5 papers), HIV/AIDS drug development and treatment (4 papers), Plant-based Medicinal Research (4 papers), Chemical synthesis and alkaloids (4 papers) and Asymmetric Hydrogenation and Catalysis (3 papers). The work is most often cited by research in Organic Chemistry (838 citations), Pharmaceutical Science (154 citations) and Inorganic Chemistry (187 citations). Nicholas A. Magnus has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Pat N. Confalone, P. Magnus, Rodney L. Parsons, William A. Nugent, Soo S. Ko, George L. Trainor, Michael A. Staszak, Sharon Diamond, Paul Anderson and Susan Jeffrey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact